US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies...
24.02.2020
- GSK is collaborating with German biopharma Immatics Biotechnologies to develop novel adoptive cell therapies (ACT) for multiple cancers. The companies will work together to...
